临床红细胞规范性输注及有效性分析  

Analysis of validity and normative of clinical red blood cell transfusion

作　　者：李青[1] 曹曰针[1] 夏荣[1] 乌宇波[1] 杨李辉[1] 

机构地区：[1]上海市复旦大学附属华山医院输血科,上海200040

出　　处：《临床血液学杂志（输血与检验）》2013年第3期370-372,共3页Journal of Clinical Hematology(Blood Transfusion & Laboratory Medicine)

基　　金：上海市公共卫生优秀学科带头人培养计划(No:GWDTR201213);重点学科建设计划(No:12GWZX0202)

摘　　要：目的:调查红细胞输注的规范性和有效性,为临床科学合理用血提供依据。方法:通过调查2011-05-12月全部红细胞输注病例,计算血红蛋白升高值,评价输血有效性。同时回顾性分析红细胞输注的规范性。结果:总计3571份红细胞输注病例,用血量为8136U,其中红细胞输注无效占15.71%,输血指针不符的输注有14.50%并有9.44%的临床输血未作血红蛋白监测。结论:临床红细胞输注存在不合理用血,无效输血,输血前后无评估现象,血制品科学使用有待进一步提高。Objective：To investigate validity and normative of clinical blood transfusion,provide basis for scientific clinical blood transfusion. Method：Through the ivestigate all red cell transfusion case between 2011.5-2011.12.Calculate the increase value of the Hemoglobin,to evaluate the effect of the red blood cell transfusion. Result：Investigate a total of 3 035 cases of blood transfusion,used 8 136 U red blood cell,in which the ineffective blood transfusion acounted for 15.71%.14.50% of the blood transfusion don＇t comply with blood transfuion pointer and 9.44% of the clinical blood transfusion without Hemoglobin monitoring as well. Conclusion：There are a lot of clinical transfusion of red cell is not reasonable transfusion,ineffective blood transfusion,don＇t do clinical monitoring before or after blood transfusion.Scientific use of blood products need to be further improved.

关 键 词：红细胞输注 无效输血 输血规范性 

分 类 号：R555[医药卫生—血液循环系统疾病]